Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · IEX Real-Time Price · USD
5.44
+0.04 (0.74%)
At close: Jul 26, 2024, 4:00 PM
5.30
-0.14 (-2.57%)
After-hours: Jul 26, 2024, 5:29 PM EDT
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $619.25 million as of July 26, 2024. Its market cap has increased by 27.42% in one year.
Market Cap
619.25M
Enterprise Value
325.44M
1-Year Change
27.42%
Ranking
Category
Stock Price
$5.44
Market Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $619.25M, an increase of 391.08%. That is a compound annual growth rate of 15.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 614.70M | 66.68% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alector | 625.54M |
| iTeos Therapeutics | 621.68M |
| Verve Therapeutics | 621.34M |
| Corbus Pharmaceuticals Holdings | 620.47M |
| Orthofix Medical | 619.61M |
| LENZ Therapeutics | 612.06M |
| Larimar Therapeutics | 607.40M |
| IRadimed | 601.68M |